Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Operating Expenses | 28,930 | 28,560 | 26,179 | 29,055 | 24,346 |
Operating Income | -28,930 | -28,560 | -26,179 | -29,055 | -24,346 |
Other Income | 1,470 | 1,017 | 400 | 149 | 92 |
Pre-tax Income | -27,460 | -27,543 | -25,779 | -28,906 | -24,254 |
Net Income Continuous | -27,460 | -27,543 | -25,779 | -28,906 | -24,254 |
Net Income | $-27,460 | $-27,543 | $-25,779 | $-28,906 | $-24,254 |
EPS Basic Total Ops | -0.58 | -0.63 | -0.69 | -0.77 | -0.65 |
EPS Basic Continuous Ops | -0.58 | -0.63 | -0.69 | -0.77 | -0.65 |
EPS Diluted Total Ops | -0.58 | -0.63 | -0.69 | -0.77 | -0.65 |
EPS Diluted Continuous Ops | -0.58 | -0.63 | -0.69 | -0.77 | -0.65 |
EPS Diluted Before Non-Recurring Items | -0.58 | -0.63 | -0.69 | N/A | N/A |
EBITDA(a) | $-28,637 | $-28,262 | $-25,879 | $-28,767 | $-24,033 |